HELP vs KOD: fair value comparison
Cybin D/B/A Helus Pharma and Kodiak Sciences Inc. · Updated 2026-10-19
HELP has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. KOD has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, HELP currently ranks higher by quality score.
| HELP | KOD | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $10.55 | $85.75 |
| 12-month range | $3.87–$14.02 | $16.90–$99.87 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #293 of 301 Healthcare | #295 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | — | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: HELP fair value analysis · KOD fair value analysis